Who We Are
Minji Jo, Ph.D., President and Independent Patient Advocate Consultant
Dr. Minji Jo has dedicated her life to the study of the biological mechanisms and genetics behind cancer for many years in academic institutes and worked on the development of cancer drugs in pharmaceutical companies for over 15 years. She has proven her expertise in these fields with nearly 30 publications in highly-regarded, peer-reviewed scientific journals.
Her extensive experience uniquely qualifies her to review and analyze treatment and clinical trial options to determine the best possible fit for patients based on each patient’s individual pathology and the genetic make-up of their cancer.
Jeannie Bristow, Ph.D., Scientific Consultant
Dr. Bristow studies the biological mechanisms underlying the metastasis of cancer cells to distant organs. She subsequently applied her knowledge to manage genomics products, including next-generation sequencing and microarray technologies in the industry. Her profound understanding of these genomic tools for studying DNA, RNA, and epigenetic alterations in the context of cancer, equips her to play a pivotal role in enlightening cancer patients about their specific cancer pathology. Furthermore, her expertise positions her to provide valuable guidance in selecting optimal treatment strategies and identifying suitable clinical trial options.